ESMO Patient Advocacy Track
Patient advocacy allows ESMO to support and promote equal access to optimal cancer treatment and care
Previously known as "ESMO Patient Seminars", these meetings fulfil one of ESMO's most important objectives – to disseminate knowledge to advocacy groups, cancer patient associations, caregivers, and the public.
ESMO 2016 Patient Advocacy Track
The role of patient advocates increases in importance as social media allow for a previously unknown direct outreach to patients and at the same time, the value of patient input into healthcare decision-making processes is recognized and systematized.
In this setting, education of patient advocates becomes critical to both ensure that patients are provided with accurate information and the input into healthcare decision-making processes is relevant. With this new concept for the advocacy track at ESMO2016, we aim to address the specific needs of the advocacy community in oncology.
Traditionally, the parallel Patient Advocacy track effectively prevented patient advocates from attending the scientific sessions relevant to their disease. For this reason, patient advocacy-specific activities will now take place on Friday, 7th, and in parallel to industry-sponsored satellite symposia during lunch and early evening hours. Cross-sectional tracks- like Public Health and Health Economics, Supportive Care and Immunotherapies are expected to be of general relevance also to the advocacy community.
For the cancer-specific tracks, patient advocacy groups of the cancer in question will identify relevant sessions- e.g. educational sessions or case discussions- that will be highlighted, appropriately introduced and potentially supported by additional reading material - aiming for a commented ESMO 2016 PA programme.
ESMO 2014 Patient Advocacy Track
27-28 September 2014, Madrid, Spain
For the first time at the ESMO 2014 Congress an entire track was dedicated to cancer patient advocates, representative of cancer leagues, healthcare professionals and industry representatives.
The event provided European patient organisations and bodies involved in patient care with an excellent networking opportunity and the possibility to discuss vital issues and challenges faced by cancer patients
The ESMO 2014 Patient Track focused on Cancer Research, Treatment and Living, Capacity Building and Patient Adovacy. The track closed with a tribute to Selma Schimmel Founder of Vital Options® International, who passed away in May 2014 from a complication of ovarian cancer.
9th ESMO Patient Seminar
Held in Vienna, Austria, on Saturday 29 and Sunday 30 September 2012
8th ESMO Patient Seminar
Held in Milan, Italy, on Saturday 9 and Sunday 10 October 2010